Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer
Conditions:   Advanced Malignant Solid Neoplasm;   Hematopoietic and Lymphoid Cell Neoplasm
Interventions:   Drug: Olanzapine;   Drug: Placebo Administration;   Other: Questionnaire Administration
Sponsors:   Mayo Clinic;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 7, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments